48 results
424B3
ACST
Acasti Pharma Inc.
7 Aug 24
Prospectus supplement
4:14pm
, the “Prior Plans”). Our success is highly dependent on our ability to attract and retain highly skilled directors, employees and consultants. To succeed, we … Plans”).
Reasons for the Approval of the 2024 Equity Incentive Plan
Our success is highly dependent on our ability to attract and retain highly skilled
424B5
eioas
10 Nov 21
Prospectus supplement for primary offering
7:23am
425
jj9gl ciofriz9y42
4 Aug 21
Business combination disclosure
5:03pm
424B3
529878cto2t uuo
15 Jul 21
Prospectus supplement
4:45pm
S-4
bquuvc
1 Jul 21
Registration of securities issued in business combination transactions
12:00am
10-Q
x756ytaijmd1u082
13 Aug 20
Quarterly report
8:30am